Pricing Log in Create free account
Saturday 17 October 2026 Export ALGN’s income statement to Excel — free account

Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

147.31 2.03 −1.36%
Market cap
$10.6B
P/E
25.6×
Fwd P/E
20.7×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Align Technology, Inc. (ALGN) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Align Technology, Inc. (ALGN) trades at a EV/EBITDA of 11.8×. Over the past ten years it has ranged from 10.8× (September 2025) to 100× (December 2020); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 13.1× (32.50%)
FY2024 19.4× (22.32%)
FY2023 24.9× 22.75%
FY2022 20.3× (56.54%)
FY2021 46.7× (45.40%)
FY2020 85.6× 149.70%
FY2019 34.3× 11.41%
FY2018 30.8× (30.29%)
FY2017 44.1× 69.54%
FY2016 26.0× 13.44%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.7× (0.89%)
Mar 2026 13.8× 5.50%
Dec 2025 13.1× 14.81%
Sep 2025 11.4× (32.97%)
42 more quarters

Against its own ten years

Low 10.8× High 100×
Ten-year median 27.4×
Current reading's percentile 1

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.6×
ATR AptarGroup, Inc. compare 11.6×
ALGN Align Technology, Inc. 11.8×
BAX Baxter International Inc. compare 14.0×
BLCO Bausch + Lomb Corporation compare 14.1×
COO The Cooper Companies, Inc. compare 14.6×
TFX Teleflex Incorporated compare 32.0×
RGEN Repligen Corporation compare 60.2×
AVTR Avantor, Inc. compare 116×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ALGN